Kamis, 23 Februari 2023

Google Alert - Elizabeth Warren

Google
Elizabeth Warren
Daily update February 24, 2023
NEWS
U.S. Senator Elizabeth Warren sent the nation's top patent regulator a letter urging close scrutiny of Merck & Co's requests for new patents on ...
Facebook Twitter Flag as irrelevant
Sen. Elizabeth Warren has sent a letter to the U.S. Patent and Trademark Office asking for intense scrutiny of Merck's attempts to extend its ...
Facebook Twitter Flag as irrelevant
Elizabeth Warren speaks at her public meet and greet in Springfield Friday afternoon, July 9, 2021. (Hoang 'Leon' Nguyen / The Republican).
Facebook Twitter Flag as irrelevant
Massachusetts U.S. Senator Elizabeth Warren was named chair of the Senate Armed Services Subcommittee on Personnel this month.
Facebook Twitter Flag as irrelevant
US Senator Elizabeth Warren is pushing for greater scrutiny on new patents for Merck & Co.'s blockbuster cancer drug Keytruda, calling into ...
Facebook Twitter Flag as irrelevant
Elizabeth Warren (D-MA) about efforts underway to better protect military families. We told you how our investigation revealed some military ...
Facebook Twitter Flag as irrelevant
Elizabeth Warren (D-MA)'s office announced Thursday that the senator, alongside Senate Health committee chair Bernie Sanders (I-VT) and Reps.
Facebook Twitter Flag as irrelevant
Elizabeth Warren, D-Mass., have urged the U.S. Patent and Trademark Office to closely examine new patents for cancer drug Keytruda, warning that ...
Facebook Twitter Flag as irrelevant
... Elizabeth Warren (D-MA), Ron Wyden (D-OR), Ben Cardin (D-MD), Chris Van Hollen (D-MD), Tammy Baldwin (D-WI), Bob Casey (D-PA), ...
Facebook Twitter Flag as irrelevant
Elizabeth Warren of Massachusetts and Democratic Rep. Sheila Jackson Lee of Texas sent a letter to the U.S. Patent and Trademarks Office to demand ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Tidak ada komentar:

Posting Komentar